SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001999371-24-002149
Filing Date
2024-02-13
Accepted
2024-02-13 16:48:30
Documents
1
Group Members
AFFINITY HEALTHCARE FUND, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G spyre-sc13ga_123123.htm SC 13G/A 83535
  Complete submission text file 0001999371-24-002149.txt   85309
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 24626950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017 917-826-4533
Affinity Asset Advisors, LLC (Filed by) CIK: 0001773195 (see all company filings)

IRS No.: 821567490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A